Leibovitch Ilan, Mor Yoram, Golomb Jacob, Ramon Jacob
Department of Urology, Chaim Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Urol. 2002 Feb;167(2 Pt 1):449-57. doi: 10.1016/S0022-5347(01)69064-5.
Postoperative chylous ascites is a rare complication of retroperitoneal and mediastinal surgery that represents a difficult management problem due to the serious mechanical, nutritional and immunological consequences of the constant loss of protein and lymphocytes. We reviewed the topic of postoperative chylous ascites with special emphasis on the relevant diagnostic and imaging modalities. We propose a novel management algorithm.
We performed a MEDLINE search of the literature on chylous ascites using chyloperitoneum as the subject heading and chylous ascites as an additional key word. The search yielded 651 articles. We focused on 102 series, collective reviews and mainly case reports related to the issue of postoperative chylous ascites.
We propose a novel algorithm based on a step-up approach aimed at promoting decreased lymph production and flow as well as maintaining nutritional balance. The management algorithm integrates repeat palliative paracentesis, dietary measures, total parenteral nutrition therapy, peritoneovenous shunting and surgical closure of the lymphoperitoneal fistula. Due to the remarkable effectiveness of somatostatin therapy for the closure of lymphatic fistula somatostatin therapy should be attempted with or without total parenteral nutrition early in the course of treatment of chylous ascites before any invasive steps are taken.
Various management modalities may be used successfully to treat chylous ascites. Therefore, treatment should be individualized and adjusted to the severity of lymphatic leakage and its consequences. The outcome mostly depends on the underlying pathological condition. Thus, in the absence of malignant or congenital underlying pathology the prognosis in cases of postoperative chylous ascites is good with the majority responding to conservative measures.
术后乳糜性腹水是腹膜后和纵隔手术的一种罕见并发症,由于蛋白质和淋巴细胞持续丢失会导致严重的机械、营养和免疫后果,因此是一个难以处理的问题。我们回顾了术后乳糜性腹水这一主题,特别强调了相关的诊断和成像方式。我们提出了一种新的管理算法。
我们使用“乳糜腹”作为主题词,“乳糜性腹水”作为附加关键词,对MEDLINE上关于乳糜性腹水的文献进行了检索。检索结果为651篇文章。我们重点关注了102篇系列研究、综述以及主要与术后乳糜性腹水问题相关的病例报告。
我们提出了一种基于逐步升级方法的新算法,旨在促进淋巴生成和流动减少,并维持营养平衡。该管理算法整合了重复姑息性腹腔穿刺术、饮食措施、全胃肠外营养治疗、腹腔静脉分流术以及淋巴腹膜瘘的手术闭合。由于生长抑素治疗对闭合淋巴瘘具有显著效果,因此在采取任何侵入性措施之前,应在乳糜性腹水治疗过程的早期尝试使用生长抑素治疗,可联合或不联合全胃肠外营养。
多种管理方式可成功用于治疗乳糜性腹水。因此,治疗应个体化,并根据淋巴漏的严重程度及其后果进行调整。结果主要取决于潜在的病理状况。因此,在没有恶性或先天性潜在病理的情况下,术后乳糜性腹水病例的预后良好,大多数对保守措施有反应。